Research ArticlePhysiology

DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis

See allHide authors and affiliations

Science Signaling  24 Mar 2015:
Vol. 8, Issue 369, pp. ra31
DOI: 10.1126/scisignal.2005835

Log in to view PDF

Log in through your institution

Log in through your institution